02:29 PM EDT, 07/29/2025 (MT Newswires) -- AIM ImmunoTech ( AIM ) shares were down over 52% in recent trading on Tuesday after the company priced its public offering of securities to raise about $8 million.

The offering comprises of 2 million shares, class E warrants to purchase up to 2 million shares, and class F warrants to also buy up to 2 million shares, and is priced at a combined price of $4.00 per share and accompanying warrants, the company said.

The class E warrants will expire on the fifth anniversary of the issuance date, while the class F warrants will expire on the 18-month anniversary of the issuance date, it added.

The closing of the offering is expected Wednesday, with Maxim Group as the placement agent, the firm said.

Price: 3.40, Change: -3.80, Percent Change: -52.78